CD80 mouse monoclonal antibody,clone OTI1G9
Applications | ELISA, FC, LMNX, WB |
Reactivities | Human |
CD80 mouse monoclonal antibody,clone OTI1G9
Applications | ELISA, FC, LMNX, WB |
Reactivities | Human |
PON1 mouse monoclonal antibody, clone OTI2D4 (formerly 2D4)
Applications | ELISA, FC, IF, IHC, WB |
Reactivities | Human |
CNY 2,700.00
CNY 4,250.00
2周
VIM biotinylated mouse monoclonal antibody, clone OTI7B10
Applications | ELISA |
Reactivities | Human |
Carrier-free (BSA/glycerol-free) SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI4C6
Applications | ELISA, WB |
Reactivities | SARS-CoV-2 |
S100A1 mouse monoclonal antibody,clone 9F3, Biotinylated
Applications | ELISA, WB |
Reactivities | Human, Mouse, Rat |
S100A1 mouse monoclonal antibody,clone 6G4, Biotinylated
Applications | ELISA, WB |
Reactivities | Human, Mouse, Rat |
S100A1 mouse monoclonal antibody,clone 6G4, HRP conjugated
Applications | ELISA, WB |
Reactivities | Human, Mouse, Rat |
SERPINB3 mouse monoclonal antibody,clone 1F10, HRP conjugated
Applications | ELISA, IHC, WB |
Reactivities | Human |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI1C2
Applications | ELISA, Neutralize |
Reactivities | SARS-CoV-2 |
CNY 3,990.00
2周
SARS-CoV-2 N Protein Mouse Monoclonal Antibody, Clone OTI3E1, HRP conjugated
Applications | ELISA, WB |
Reactivities | SARS-CoV-2 |
CNY 3,990.00
2周
SARS-CoV-2 N Protein Mouse Monoclonal Antibody, Clone OTI8G10, HRP conjugated
Applications | ELISA, WB |
Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI4C6, HRP conjugated
Applications | ELISA, WB |
Reactivities | SARS-CoV-2 |
CNY 3,990.00
2周
SARS-CoV-2 N Protein Mouse Monoclonal Antibody, Clone OTI10B2, HRP conjugated
Applications | ELISA, WB |
Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI3H6, HRP conjugated
Applications | ELISA, WB |
Reactivities | SARS-CoV-2 |
SARS-CoV-2 Spike protein mouse monoclonal antibody, clone OTI3A2, HRP conjugated
Applications | ELISA, WB |
Reactivities | SARS-CoV-2 |